Locations:
Search
A proactive, framework-based approach
Patients on ibrutinib were more than twice as likely to experience atrial fibrillation or heart failure than those on second-generation alternatives.
Expert recommendations introduce use of targeted agents
Combination therapy may soon represent new standard of care
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Adequate dosing may improve outcomes in well-selected patients, large Cleveland Clinic series suggests
Research findings offer clues for improving disease outcomes in men
Creating a safe space for patients
Long-term immune effects reshape preventative strategies and timelines
Large-scale database also reveals potential for immunotherapy to protect against cancer
Findings may help guide discussions around prognosis and allogeneic stem cell transplantation
Advertisement
Advertisement